Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Coating Increases Clinical Utility of Cardiac Stem Cells

By LabMedica International staff writers
Posted on 22 Jan 2018
The effectiveness of cardiac stem cells for repairing heart disease damage is dramatically increased when the cells are covered with a coating of platelet adhesion molecules.

Stem cell transplantation, as used clinically, suffers from low retention and engraftment of the transplanted cells. More...
Inspired by the ability of platelets to recruit stem cells to sites of injury on blood vessels, investigators at North Carolina State University (Raleigh, USA) hypothesized that platelets might enhance the vascular delivery of cardiac stem cells (CSCs) to sites of myocardial infarction injury.

To test this hypothesis, the investigators generated cardiac stem cells and then covered their surface membranes with nanovesicles prepared from platelet adhesion glycoprotein molecules.

The investigators reported in the January 10, 2018, online edition of the journal Nature Biomedical Engineering that CSCs with platelet nanovesicles fused onto their surface membranes expressed platelet surface markers that were associated with platelet adhesion to injury sites. The modified CSCs selectively bound collagen-coated surfaces and endothelium-denuded rat aortas, and in rat and pig models of acute myocardial infarction the modified CSCs increased retention in the heart and reduced infarct size.

“Platelets can home in on an injury site and stay there, and even in some cases recruit a body’s own naturally occurring stem cells to the site, but they are a double-edged sword,” said senior author Dr. Ke Cheng, associate professor of veterinary medicine at North Carolina State University. “That is because once the platelets arrive at the site of injury, they trigger the coagulation processes that cause clotting. In a heart-attack injury, blood clots are the last thing that you want.”

“The nanovesicle is like the platelet’s coat,” said Dr. Cheng. “There is not any internal cellular machinery that could activate clotting. When you place the nanovesicle on the stem cell, it is like giving the stem cell a tiny GPS that helps it locate the injury so it can do its repair work without any of the side effects associated with live platelets. Platelet nanovesicles do not affect the performance of the cardiac stem cells, and are free from any negative side effects. Hopefully we will be able to use this approach to improve cardiac stem cell therapy in clinical trials in the future.”

Related Links:
North Carolina State University


Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
New
Gold Member
Serum Indices Control
Acusera Serum Indices Control
New
Automated Immunoassay Analyzer
SuperFlex™
Gold Member
Platelet Function Analyzer
PL-12
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Researchers from the Department of Chemistry at Aarhus University have developed and tested a new technology that can identify and measure the concentration of pharmaceuticals in under 10 minutes. Today, this process takes up to an hour. That is critical waiting time for patients suffering from a stroke. (Image Credit: Aarhus University)

Point-of-Care Blood Test Could Speed Treatment Decisions in Acute Stroke

Minutes can shape treatment decisions in emergency stroke care, particularly when physicians need to know whether a patient is taking anticoagulants before administering clot-dissolving therapy.... Read more

Microbiology

view channel
Image: The clearance also broadens QIAstat-Dx\'s infectious disease testing menu in the U.S., which already includes panels for respiratory and gastrointestinal infections, as well as meningitis and encephalitis (Photo courtesy of Qiagen)

One-Hour Molecular Panel Expands Bloodstream Infection Testing for Gram-Negative Pathogens

Bloodstream infections can progress rapidly and lead to sepsis, organ failure, and death. In the United States, about 1.7 million adults develop sepsis each year, and at least 350,000 die during hospitalization... Read more

Industry

view channel
Image

Collaboration Combines AI Cognitive Assessment and RNA Blood Testing for Earlier Alzheimer’s Detection

Alzheimer’s disease is often identified only after substantial neurodegeneration, partly because current diagnostic pathways are fragmented and difficult to scale. As treatment shifts toward earlier intervention,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.